Experts Discuss Strategies to Lower Breast Cancer Mortality Rates

Breast cancer remains a significant health concern, particularly for women aged 50 and older, who account for approximately 83% of annual diagnoses. On August 14, 2024, Dr. Steven Narod, a leading expert in the field and Tier I Canada Research Chair in Breast Cancer at the University of Toronto, discussed strategies to reduce the mortality risk associated with this prevalent disease during an interview with Jeffrey Snyder of the Broadcast Retirement Network.

Understanding Breast Cancer Prevalence

Dr. Narod highlighted that breast cancer is the most common cancer among women, with an estimated 8% of Canadian women developing the disease by age 75. This statistic reflects a trend seen in various countries, including the United States, where rates are similarly high. In contrast, breast cancer rates tend to be lower in Asian countries compared to regions in Africa.

When examining the reasons for these differences, Narod suggested various factors, including genetic predispositions and lifestyle influences. He pointed out that increased screening efforts, particularly mammography, might also contribute to the higher detection rates in Western countries. “Some cancers identified through screening may never become clinically apparent,” he noted, referencing the issue of over-diagnosis.

Treatment Protocols and Their Evolution

The treatment landscape for breast cancer has evolved significantly over the past few decades. According to Dr. Narod, since the 1980s, chemotherapy has been administered to around half of the women diagnosed with the disease. Surgical options vary, with procedures including lumpectomies—where only the cancerous tissue is removed—and mastectomies, which involve the removal of one or both breasts. The choice of treatment often depends on multiple factors, including tumor size and the patient’s personal risk factors.

For those with estrogen receptor-positive cancers, anti-hormonal therapies such as Tamoxifen are common. These medications aim to block estrogen, which can promote cancer growth. In some cases, particularly for women with a BRCA1 mutation, more aggressive surgical options, including bilateral mastectomies, may be considered to mitigate future cancer risks.

Dr. Narod’s research team has investigated the implications of bilateral mastectomies, revealing that about 5% of women with breast cancer in one breast choose to have both removed. This decision is often influenced by a desire to avoid a second cancer, which occurs in approximately 7% of women over a 20-year period. Yet, paradoxically, the study found that undergoing a bilateral mastectomy did not significantly lower mortality rates compared to other treatment options.

“The mortality rate in women undergoing unilateral mastectomy, lumpectomy, or bilateral mastectomy was similar over a 20-year period,” Dr. Narod stated, emphasizing the need for further research.

Future Directions in Research and Prevention

As research continues, Dr. Narod plans to delve deeper into the biological mechanisms behind breast cancer and metastasis. His findings challenge the conventional understanding of how contralateral breast cancers develop and their potential to affect mortality rates. “We need to investigate the origins and characteristics of these cancer cells to better understand their behavior,” he explained.

Prevention remains a critical topic, especially for high-risk individuals. The conversation around preventive measures includes discussing lifestyle choices, with some studies indicating that alcohol consumption may increase breast cancer risk. While genetic screening can identify women who might benefit from preventive surgeries, the majority of breast cancer cases do not arise from hereditary mutations.

Detecting breast cancer at an early stage is vital. While magnetic resonance imaging (MRI) is more sensitive and effective, mammography is still the standard for routine screening, typically recommended for women over the age of 40 or 50. Dr. Narod pointed out ongoing debates about the optimal age to begin screening and the frequency of mammograms.

In summary, while breast cancer remains a leading health issue, advancements in research and treatment protocols provide hope for better outcomes. Dr. Narod’s work continues to unravel the complexities of the disease, aiming to improve survival rates and quality of life for women facing this diagnosis.